Industry Focus
Healthcare: These Two Stocks Are On Different Paths, But Both Remain Risky
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:19:55
- Mas informaciones
Informações:
Sinopsis
The Motley Fool discusses how investors might want to think about Valeant Pharmaceuticals' share price tailspin and marijuana drugmaker GW Pharmaceuticals' skyrocketing valuation.
